Melanoma Posts Page 2 on Medivizor
Navigation Menu

Melanoma Posts on Medivizor

Pembrolizumab improves stage 3 melanoma outcomes

Posted by on Jun 4, 2018 in Melanoma | 0 comments

In a nutshell This study investigated the effectiveness of pembrolizumab (Keytruda) in the treatment of patients with stage 3 melanoma who underwent surgery. Researchers suggested that this drug is associated with longer recurrence-free survival with no new side effects. Some background The use of PD-1 antibodies, such as pembrolizumab, in patients...

Read More

Vitamin D is associated with melanoma outcomes

Posted by on May 6, 2018 in Melanoma | 0 comments

In a nutshell This study investigated if low levels of vitamin D are associated with worse melanoma prognosis. Researchers suggested that low levels of vitamin D are associated with worse outcomes in metastatic (spread to other parts of the body) melanoma. Some background Recent studies have suggested that a low vitamin D level (less than 20...

Read More

A review on new therapies to treat metastatic melanoma

Posted by on Apr 20, 2018 in Melanoma | 0 comments

In a nutshell This study reviewed other studies about different treatments for metastatic (spread to other parts of the body) melanoma. Researchers suggested that targeted therapy improves overall survival of these patients when compared to chemotherapy. Some background Melanoma is the most dangerous common skin cancer. 70 to 80% of patients are...

Read More

Multiple primary tumors does not change survival rates in melanoma patients

Posted by on Apr 9, 2018 in Melanoma | 0 comments

In a nutshell This study compared survival rates between melanoma patients with multiple primary melanoma (MPM) and single primary melanoma (SPM). Researchers suggested that MPM and SPM patients have similar survival rates. Some background An estimated 87,110 Americans were diagnosed with advanced melanoma in 2017. New melanoma cases are projected to...

Read More

Treatment with vemurafenib plus cobimetinib does not affect health related quality of life in advanced melanoma patients

Posted by on Apr 1, 2018 in Melanoma | 0 comments

In a nutshell This study examined the side effects and health related quality of life (HRQL) of advanced melanoma patients treated with cobimetinib (Cotellic) plus vemurafenib (Zelboraf). Researchers suggested that these patients maintained their HRQL when compared with patients treated with vemurafenib alone. Some background Prior studies...

Read More

Tumor thickness as a prognostic factor for melanoma patients

Posted by on Mar 19, 2018 in Melanoma | 0 comments

In a nutshell This study investigated the relationship between tumor thickness and melanoma prognosis. Researchers suggested that patients with less than 0.8 mm thick tumors have an improved prognosis.  Some background Primary tumor thickness is the most important predictor of melanoma outcomes. The current melanoma staging system defines the...

Read More

5 Things You Probably Didn’t Know About Your Adrenal Glands

5 Things You Probably Didn’t Know About Your Adrenal Glands

Posted by on Mar 15, 2018 in Benign prostatic hyperplasia, Blog, Breast cancer, Colorectal cancer, Coronary artery disease, Diabetes mellitus, Erectile dysfunction, Hodgkin's lymphoma, Hypertension, Infertility, Kidney stones, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Non-Hodgkin lymphoma, Prostate cancer, Rheumatoid Arthritis, Stroke, Urinary incontinence, Urinary tract infection | 3 comments

The adrenal glands-which are also called suprarenal glands-are part of the endocrine system and are found on the top of each kidney. How the endocrine system hormones work Hormones secreted from glands of the endocrine system travel in the bloodstream to target cells. Target cells have receptors that are specific to each hormone. The hormones and receptors...

Read More

Right To Try: Needed Legislation or Snake Oil?

Right To Try: Needed Legislation or Snake Oil?

Posted by on Mar 10, 2018 in Blog, Breast cancer, Colorectal cancer, Hodgkin's lymphoma, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Non-Hodgkin lymphoma, Prostate cancer | 1 comment

Thirty-eight states in the US have passed “Right To Try” laws. These are laws that are created to give terminally ill patients who have run out of options access to experimental drugs that have not completed the FDA approval process.  There is an effort underway to pass this type of legislation on a federal level. On February 8, the #LCSM (Lung...

Read More

To Treat or Not To Treat Cancer: Medical Decision-making

To Treat or Not To Treat Cancer: Medical Decision-making

Posted by on Jan 28, 2018 in Blog, Breast cancer, Colorectal cancer, Hodgkin's lymphoma, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Non-Hodgkin lymphoma, Prostate cancer | 9 comments

Cherry Hughes** is an active, energetic 75 year old, still working in the marketing and public relations profession in Great Britain.  Her life is filled with friends and fun.  “I love cooking and eating out.  I am deeply interested in politics.  I love music …I go to jazz clubs.  I love going to France …I have a little apartment...

Read More

What is Neutropenia?

What is Neutropenia?

Posted by on Jan 21, 2018 in Blog, Breast cancer, Colorectal cancer, Hodgkin's lymphoma, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Non-Hodgkin lymphoma, Prostate cancer | 1 comment

There are 1.6 million people diagnosed with cancer in the US each year. Of these, 650,000 receive chemotherapy. Did you know that 60,000 people a year are hospitalized for neutropenia, a common side effect of chemotherapy? One in fourteen die because of it. Of the 650,000 receiving chemotherapy, 104,000 are not aware of neutropenia and 52,000 don’t...

Read More